Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
38.14
-1.07 (-2.73%)
May 1, 2026, 4:00 PM EDT - Market closed
Liquidia Market Cap
Liquidia has a market cap or net worth of $3.39 billion as of May 1, 2026. Its market cap has increased by 190.55% in one year.
Market Cap
3.39B
Enterprise Value
3.40B
1-Year Change
190.55%
Ranking
Category
Stock Price
$38.14
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.77M to $3.39B, an increase of 1,920.81%. That is a compound annual growth rate of 47.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 3.39B | 13.00% |
| Dec 31, 2025 | 3.00B | 201.46% |
| Dec 31, 2024 | 995.33M | 20.97% |
| Dec 29, 2023 | 822.82M | 100.28% |
| Dec 30, 2022 | 410.83M | 62.30% |
| Dec 31, 2021 | 253.13M | 98.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkermes | 5.63B |
| Lantheus Holdings | 5.52B |
| Kiniksa Pharmaceuticals International, | 4.14B |
| Amneal Pharmaceuticals | 4.11B |
| Supernus Pharmaceuticals | 2.76B |
| Prestige Consumer Healthcare | 2.68B |
| BioCryst Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 2.28B |